tirzepatide prescribing guidelines TrimRX Mounjaro (Tirzepatide) Prescribing Update –

Heres what you can expect during your first visit

Int Immunopharmacol 143(Pt 2):113499 Silva-Veiga FM, Marinho TS, de Souza-Mello V, Aguila MB, Mandarim-de-Lacerda CA (2025) Tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), positively impacts the altered microbiota of obese, diabetic, ovariectomized mice

This is reflected in the trial data where every single participant lost at least 5% of their body weight, which is unheard of in obesity studies

Weight Loss Drugs in 2025: New and Effective Options FDA-Approved Weight Loss Medications The weight loss medication landscape has transformed significantly by 2025